Fingerprint
Dive into the research topics of 'N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: A North Central Cancer Treatment Group (NCCTG) Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically